Study protocol for a randomized single-center cross-over study: Dapagliflozin treatment in recurring kidney stone ...
Urolithiasis is one of the most common diseases worldwide, characterized by high morbidity and significant treatment-related costs, with a rising prevalence of up to 20%. The relapse rate within the first 10 years after initial treatment is estimated to be …